MedTrace Logo

The Effect of Vitamin D Supplementation on Cardiovascular Risk Factors

NCT02750293 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 411

Last updated 2017-10-26

No results posted yet for this study

Summary

Six-hundred subjects with vitamin D deficiency will be randomized to vitamin D 3000 IU per day versus placebo for 4 months, with effects on cardiovascular risk factors as main endpoint

Conditions

  • Vitamin D Deficiency

Interventions

DRUG

Cholecalciferol

Vitamin D preparation

DRUG

Placebo

placebo

Sponsors & Collaborators

  • University of Tromso

    lead OTHER

Principal Investigators

  • rolf Jorde, Professor · University of Tromso

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-06-30
Primary Completion
2017-08-31
Completion
2017-09-30

Countries

  • Norway

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02750293 on ClinicalTrials.gov